Posttransplant lymphoproliferative disease of donor origin
Nalesnik, M.A.
Archives of Pathology and Laboratory Medicine 121(7): 665-666
1997
ISSN/ISBN: 0003-9985 PMID: 9240898 Document Number: 480767
Document emailed within 1 workday
Related Documents
Hegele, R.G.; Bicknell, S.G.; Bailey, D.J.; Cameron, R.G. 1994: In situ hybridization for the Y chromosome reveals a donor origin for a posttransplant lymphoproliferative disorder in a sex-mismatched hepatic allograft Archives of Pathology and Laboratory Medicine 118(8): 795-796Hudnall, S.D.; Melez, K.; Galindo, A.; Bryson, Y. 1996: Massive pseudolymphomatous pericardial effusion in the posttransplant setting mimicking posttransplant lymphoproliferative disease Transplantation 61(12): 1776-1778
Donovan, J.A.; Simmons, F.A.; Esrason, K.T.; Jamehdor, M.; Busuttil, R.W.; Novak, J.M.; Grody, W.W. 1997: Donor origin of a posttransplant liver allograft malignancy identified by fluorescence in situ hybridization for the Y chromosome and DNA genotyping Transplantation 63(1): 80-84
Cheung, A.N.; Chan, A.C.; Chung, L.P.; Chan, T.M.; Cheng, I.K.; Chan, K.W. 1998: Post-transplantation lymphoproliferative disorder of donor origin in a sex-mismatched renal allograft as proven by chromosome in situ hybridization Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 11(1): 99-102
Nalesnik, M.A.; Locker, J.; Jaffe, R.; Demetris, A.J.; Hartle, K.; Burnham, J.A.; Makowka, L.; Starzl, T.E. 1988: Clonal characteristics of posttransplant lymphoproliferative disorders Transplantation Proceedings 20(1 Suppl 1: 280-283
Darenkov, I.A.; Marcarelli, M.A.; Basadonna, G.P.; Friedman, A.L.; Lorber, K.M.; Howe, J.G.; Crouch, J.; Bia, M.J.; Kliger, A.S.; Lorber, M.I. 1997: Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy Transplantation 64(6): 848-852
Smir, B.N.; Hauke, R.J.; Bierman, P.J.; Gross, T.G.; d'Amore, F.; Anderson, J.R.; Greiner, T.C. 1996: Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders Laboratory Investigation; a Journal of Technical Methods and Pathology 75(4): 575-588
Godyn, J.J.; Hicks, D.G.; Hsu, S.H.; Kant, J.; Montone, K.T.; Zmijewski, C.M.; Tomaszewski, J.E. 1992: Demonstration of passenger leukocytes in a case of Epstein-Barr virus posttransplant lymphoproliferative disorder using restriction fragment length polymorphism analysis Archives of Pathology and Laboratory Medicine 116(3): 249-252
Lager, D.J.; Slagel, D.D.; Burgart, L.J. 1993: Detection of Epstein-Barr virus DNA in sequential renal transplant biopsy specimens using the polymerase chain reaction. Report of a patient with a posttransplant lymphoproliferative disorder Archives of Pathology and Laboratory Medicine 117(3): 308-312
Sokal, E.M.; Antunes, H.; Beguin, C.; Bodeus, M.; Wallemacq, P.; de Ville de Goyet, J.; Reding, R.; Janssen, M.; Buts, J.P.; Otte, J.B. 1997: Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus Transplantation 64(10): 1438-1442
Keown, P.A.; Stiller, C.R.; Bloch, M.; Sinclair, N.R.; Lockwood, B.A.; Howson, W.H. 1981: Pretransplant immunologic reactivity to donor lymphocytes--lack of correlation with posttransplant events Transplantation Proceedings 13(3): 1563-1564
Dharnidharka, V.R.; Sullivan, E.K.; Stablein, D.M.; Tejani, A.H.; Harmon, W.E. 2001: Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) Transplantation 71(8): 1065-1068
Meignin, V.; Devergie, A.; Brice, P.; Brison, O.; Parquet, N.; Ribaud, P.; Cojean, I.; Gaulard, P.; Gluckman, E.; Socie, G.; Janin, A. 1998: Hodgkin's disease of donor origin after allogeneic bone marrow transplantation for myelogeneous chronic leukemia Transplantation 65(4): 595-597
Kobayashi, S.; Ochiai, T.; Hori, S.; Suzuki, T.; Shimizu, T.; Gunji, Y.; Shimada, H.; Yamamoto, S.; Ogawa, A.; Kohno, Y.; Sunaga, M.; Shimazu, M.; Tanaka, K. 2001: Copper metabolism after living donor liver transplantation for hepatic failure of Wilson's disease from a gene mutated donor Hepato-Gastroenterology 48(41): 1259-1261
Boström, L.; Ringdén, O.; Forsgren, M. 1992: Strong donor mononuclear cell reactivity for herpes simplex virus antigen in immune donor/recipient pairs is associated with acute graft-versus-host disease Transplantation Proceedings 24(1): 376-377
Davis, S.F.; Yeung, A.C.; Meredith, I.T.; Charbonneau, F.; Ganz, P.; Selwyn, A.P.; Anderson, T.J. 1996: Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant Circulation 93(3): 457-462
Załeska, J.; Chojak-Figura, E.; Lesiak, B. 1984: Pulmonary aspergillosis in lymphoproliferative disease Pneumonologia Polska 52(5): 257-263
Lewkonia, R.M.; Pineo, G.F. 1982: Angioedema-like skin lesions associated with lymphoproliferative disease Canadian Medical Association Journal 127(9): 867-868
Herrmann, J.B. 1971: Lymphoproliferative disease secondary to breast cancer New York State Journal of Medicine 71(10): 1108-1111
Foss, F.M. 2009: The importance of accurately characterizing lymphoproliferative disease Oncology 23(13): 1168; 1170